0 results for 'Foley Lardner'
Perseverance Gets Genentech Back to Agensys' Table
In 2002 Alan Mendelson, of Latham & Watkins, ensured that Agensys Inc. had enough property and cash to put together a private placement that brought in $42 million. And Agensys' IP portfolio was strong enough to attract biotech giant Genentech Inc.'s attention. Two years before the funding came in, Agensys had signed a $30 million licensing deal with Genentech. Agensys' future looked bright -- but then the Genentech deal tanked.Tech Circuit: Mayan Year 5,126 Edition
The legal technology community predicts unexpected trends for 2013, including changes in e-discovery, cloud computing, and information governance. [MORE]Upcoming Trial Highlights Disclosure Requirements of Biotech Companies
In a civil fraud action set for a May trial, the SEC argues that Biopure, its GC Jane Kober and two former executives misled investors about the prospects for Hemopure, a blood substitute that is the company's flagship product. The outcome will provide important guidance to other biotechnology outfits, particularly those built around a single product. One major issue in the case is an undeniably upbeat Biopure press release that came after the FDA suspended review of Hemopure pending more information.Games Lawyers Play: Backdating Edition
We compare the recently exposed Mercury complaint to the reasons Orrick and Shearman gave to keep it hidden. No Subscription RequiredE-Verify Primarily A Volunteer Program, For Now
The Senate plan to overhaul federal immigration law would phase in mandatory use of E-Verify by employers over five years.A federal judge in Madison, Wisconsin ruled that the IRS's claim didn't belong in federal court. Instead, she ruled, the government needs to fight this matter in the state court overseeing Ambac's reorganization.
How worried is the IRS that Ambac will spend a disputed $708 million "quickie refund" it received in Feb. 2010? So worried that it has taken the apparently unprecedented step of naming the Wisconsin state court that approved an Ambac restructuring plan as a defendant in a suit to enjoin Ambac from disbursing the money--even though the IRS hasn't even filed a formal claim to the $708 million.
Trending Stories
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
White Collar Investigation Practice: Global Expertise in Complex Investigations
Brought to you by HaystackID
Download Now
Criminal Division's Evaluation of Corporate Compliance Programs: September 2024 Updates Review
Brought to you by NAVEX Global
Download Now
Data Management and Analytics: The Key to Success for Legal Operations
Brought to you by DiliTrust
Download Now
Small Law Firm Playbook: The Expert's Guide to Getting the Most Out of Legal Software
Brought to you by PracticePanther
Download Now